Chorionic Gonadotrophin for injection

Contraindication

Patients suspected of having pituitary hyperplasia or swelling and pain, prostate cancer or other androgen-related swelling and pain tumors are contraindicated (with promoting effect). Patients with precocious puberty, vaginal bleeding with an undiagnosed diagnosis, subordinate fibroids, ovarian cysts or ovarian enlargement, thrombophlebitis, and patients with a history of allergy to gonadal stimulating hormones are contraindicated.

Notice

1. It should be used with caution in the following conditions: enlarged prostate, asthma, epilepsy, heart disease, migraine, renal impairment, etc.
2. If ovarian hyperstimulation syndrome and ovarian enlargement, pleural effusion, ascites and other comorbidities are found, the drug should be discontinued or seek medical advice.
3. The possibility of multiple pregnancies should be communicated to the patient before use. Ask about adverse reactions during use and conduct relevant clinical examinations regularly.
4. Pregnancy tests can be falsely positive and should be tested 10 days after administration.
5. Use with caution in patients with hypertension.
6. This product is temporarily formulated before application.